ORG Partners’s GeneDx Holdings WGS Stock Holding History

ORG Partners’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5	Closed	-$422	–	1629
2025 Q1	$422	Buy	+5	New	+$434	﹤0.01%	1290

Other funds holding WGS

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

ORG Partners's WGS Position: Q2 2025 in Review

ORG Partners sold out of GeneDx Holdings (WGS) in Q2 2025, closing a stake of 5 shares — an estimated $422 sold.

ORG Partners first reported a position in WGS in Q1 2025 and held it in 1 quarter. The position peaked at $422 in Q1 2025. 231 funds tracked by Wall St. Rank hold WGS as of Q2 2025.

ORG Partners reported no remaining GeneDx Holdings position as of Q2 2025 after selling out during the quarter.
ORG Partners sold 5 GeneDx Holdings shares in Q2 2025, an estimated $422.
ORG Partners first reported a position in GeneDx Holdings in Q1 2025 and held it in 1 quarter.
ORG Partners's GeneDx Holdings position peaked at $422 in Q1 2025.
231 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2025.

Based on ORG Partners's 13F filing for Q2 2025, filed 16 Jul 2025.